HEPATIC DYSFUNCTION AND ITS RELATION WITH SEVERITY OF ASPHYXIA IN NEONATES
DOI:
https://doi.org/10.65035/c8meqh71Keywords:
Perinatal Asphyxia, Hepatic Dysfunction, Liver Enzymes, Alt, Ast, Ldh, Neonates, Multi-Organ DysfunctionAbstract
Background: Perinatal asphyxia (PA) is a significant cause of neonatal morbidity and mortality, and may cause multi-organ dysfunction, including liver injury. Hepatic dysfunction, which is indicated by an increase in liver enzymes, is common in neonates with PA but poorly researched.
Objective: The importance of hepatic dysfunction in neonates with perinatal asphyxia and its relation to the degree of asphyxia.
Methods: The study was descriptive cross-sectional research whose sample consisted of the Department of Pediatric Medicine and Allama Iqbal Teaching Hospital, Dera Ghazi Khan in the duration from 13th February, 2024 to 13th August, 2024. One hundred and fifty neonates with perinatal asphyxia were involved. Liver enzymes (ALT, AST, and LDH) were detected, and the intensity of asphyxia was determined according to the Levene scale.
Results: The researchers have discovered that the levels of ALT, AST, and LDH were significantly increased with the severity of PA, and peak levels were observed in severe cases. In severe PA, hepatic dysfunction was more common.
Conclusion: The severity of perinatal asphyxia is closely linked to hepatic dysfunctions, and liver enzyme levels could be used as early warning signs in measuring the severity of asphyxia and to inform intervention.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dr Hafiz Muhammad Yasin, Dr Shakeel Ahmid Laghari, Dr Sonia Ilyas, Dr Irum Jabeen, Dr Asma Akber, Dr Maria Tanveer (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Journal of Medical & Health Sciences Review (JMHSR) remain the copyright of their respective authors. JMHSR publishes its content under the Creative Commons Attribution‑NonCommercial 4.0 International License (CC BY‑NC 4.0), which allows readers to freely share, copy, adapt, and build upon the work for non‑commercial purposes, provided proper credit is given to both the authors and the journal.



